# Observational Hidradenitis Suppurativa studies: 31 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials that are observational for Hidradenitis Suppurativa that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Hidradenitis Suppurativa studies: 31 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/hidradenitis-suppurativa

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 31
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944196 | Gut Microbiome Diversity in Adults With Inflammatory and Immune-Mediated Skin Diseases | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Observational | Recruiting | Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa (HS), Vitiligo - Macular Depigmentation, Alopecia Areata, Acne... | 694 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944196) |
| September 4, 2026 | NCT07805798 | Urinary Bladder Matrix (UBM) Registry | Integra LifeSciences Corporation | Observational | Not yet recruiting | Tissue Repair, Soft Tissue Reconstruction, Wound Management, Pressure Ulcer (PU), Necrotizing Soft Tissue Infection... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805798) |
| September 4, 2026 | NCT07804134 | Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in... | Medisch Spectrum Twente | Observational | Not yet recruiting | Psoriasis, Eczema/Atopic Dermatitis, Hidradenitis Suppurativa (HS) | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804134) |
| August 10, 2026 | NCT07755670 | Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI | Second Xiangya Hospital of Central South University | Observational | Recruiting | Hidradenitis Suppurativa (HS) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755670) |
| August 5, 2026 | NCT07748169 | An Observational Study of Patients With Dermatologic Disease | Target PharmaSolutions, Inc. | Observational | Not yet recruiting | Vitiligo, Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa (HS) | 2,000,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748169) |
| July 8, 2026 | NCT07690319 | A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients | Novartis Pharmaceuticals | Observational | Not yet recruiting | Hidradenitis Suppurativa | 186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690319) |
| June 22, 2026 | NCT07659769 | Global Healthcare Study on Hidradenitis Suppurativa | Sponsor not shown (see the record) | Observational | Recruiting | Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa) | 9,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07659769) |
| April 21, 2026 | NCT07543419 | Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With... | Novartis Pharmaceuticals | Observational | Recruiting | Hidradenitis Suppurativa | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543419) |
| March 6, 2026 | NCT07454889 | A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With... | Novartis Pharmaceuticals | Observational | Not yet recruiting | Hidradenitis Suppurativa | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454889) |
| January 13, 2026 | NCT07336641 | LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice | Fondazione ISIDE | Observational | Not yet recruiting | Psoriasis, Atopic Dermatitis, Vitiligo, Alopecia Areata, Hidradenitis Suppurativa | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336641) |
| December 15, 2025 | NCT07282015 | Real-world Secukinumab Outcomes in Canadian HS Patients | Novartis Pharmaceuticals | Observational | Recruiting | Hidradenitis Suppurativa | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07282015) |
| November 24, 2025 | NCT07243782 | Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab)... | Novartis Pharmaceuticals | Observational | Recruiting | Hidradenitis Suppurativa, Pediatric Plaque Psoriasis, Juvenile Idiopathic Arthritis | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243782) |
| August 22, 2025 | NCT07136467 | A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis... | AbbVie | Observational | Recruiting | Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa | 2,795 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07136467) |
| August 14, 2025 | NCT07123038 | A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg)... | Sonoma Biotherapeutics, Inc. | Observational | Recruiting | Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07123038) |
| August 7, 2025 | NCT07109765 | Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa | Peking Union Medical College | Observational | Recruiting | Hidradenitis Suppurativa (HS) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07109765) |
| June 15, 2025 | NCT07021495 | SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) | Leiden University Medical Center | Observational | Recruiting | Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/... | 840 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07021495) |
| April 13, 2025 | NCT06926192 | Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa | Peking Union Medical College | Observational | Recruiting | Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa), Secukinumab | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06926192) |
| January 21, 2025 | NCT06785779 | Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia | Novartis Pharmaceuticals | Observational | Recruiting | Hidradenitis Suppurativa (HS) | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06785779) |
| September 19, 2024 | NCT06599411 | Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa, Lichen Planus, Cutaneous Lupus, Dermatomyositis, Cutaneaous... | 830 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06599411) |
| April 17, 2024 | NCT06370052 | Pathophysiological Basis of Hidradenitis Suppurativa | Clinical Hospital Center Rijeka | Observational | Not yet recruiting | Hidradenitis Suppurativa | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06370052) |
| April 16, 2024 | NCT06368388 | Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI) | Universitaire Ziekenhuizen KU Leuven | Observational | Recruiting | Musculoskeletal Infection, Chronic Rhinosinusitis (Diagnosis), Persistent Bacteremia, Pulmonary Infection, Hidradenitis... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06368388) |
| January 11, 2024 | NCT06201858 | A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa | Power Life Sciences Inc. | Observational | Not yet recruiting | Hidradenitis Suppurativa | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06201858) |
| August 16, 2023 | NCT05994976 | Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers | Innovaderm Research Inc. | Observational | Recruiting | Acne, Atopic Dermatitis, Chronic Hand Eczema, Hidradenitis Suppurativa, Plaque Psoriasis, Palmoplantar Pustulosis | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05994976) |
| July 3, 2023 | NCT05928169 | Determinants of Chronic Inflammatory Skin Disease Trajectories | University Hospital Schleswig-Holstein | Observational | Recruiting | Atopic Dermatitis, Psoriasis, Lichen Planus, Alopecia Areata, Hidradenitis Suppurativa, Prurigo Nodularis, Cutaneous... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05928169) |
| August 18, 2022 | NCT05507125 | Regulation of Inflammatory Genes in Hidradenitis Suppurativa | University of Alabama at Birmingham | Observational | Recruiting | Hidradenitis Suppurativa | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05507125) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 6 |
| Peking Union Medical College | 2 |
| University of California, San Francisco | 2 |
| Aroa Biosurgery Limited | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| Ohio State University | 1 |
| Clinical Hospital Center Rijeka | 1 |
| University Hospital Schleswig-Holstein | 1 |
| Target PharmaSolutions, Inc. | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| University of Alabama at Birmingham | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| [Integra LifeSciences Corporation](https://specstream.ai/data/clinical-trials/company/integra-lifesciences-corporation) | 1 |
| Leiden University Medical Center | 1 |
| University of Massachusetts, Worcester | 1 |
| Medisch Spectrum Twente | 1 |
| Innovaderm Research Inc. | 1 |
| Sonoma Biotherapeutics, Inc. | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Fondazione ISIDE | 1 |
| Second Xiangya Hospital of Central South University | 1 |
| [Power Life Sciences Inc.](https://specstream.ai/data/clinical-trials/company/power-life-sciences-inc) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 9 |
| Italy | 4 |
| China | 3 |
| Canada | 3 |
| France | 3 |
| Germany | 2 |
| South Korea | 2 |
| Switzerland | 2 |
| Netherlands | 2 |
| Argentina | 1 |
| Colombia | 1 |
| Czechia | 1 |
| Estonia | 1 |
| Greece | 1 |
| Japan | 1 |
| Latvia | 1 |
| Puerto Rico | 1 |
| Romania | 1 |
| Spain | 1 |
| Taiwan | 1 |
| United Kingdom | 1 |
| Belgium | 1 |
| Saudi Arabia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
- [Commercial refrigeration companies in the United States](https://specstream.ai/data/businesses/commercial-refrigeration-companies/united-states)
- [Persian restaurants in the United States](https://specstream.ai/data/businesses/persian-restaurants/united-states)
- [Cajun and Creole restaurants in the United States](https://specstream.ai/data/businesses/cajun-and-creole-restaurants/united-states)
- [Occupational safety services in the United States](https://specstream.ai/data/businesses/occupational-safety-services/united-states)
- [Basque restaurants in the United States](https://specstream.ai/data/businesses/basque-restaurants/united-states)
